Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82


Approaches to the assessment of severe asthma: barriers and strategies.

Majellano EC, Clark VL, Winter NA, Gibson PG, McDonald VM.

J Asthma Allergy. 2019 Aug 23;12:235-251. doi: 10.2147/JAA.S178927. eCollection 2019.


Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline.

Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, Gaga M, Kellermeyer L, Khurana S, Knight S, McDonald VM, Morgan RL, Ortega VE, Rigau D, Subbarao P, Tonia T, Adcock IM, Bleecker ER, Brightling C, Boulet LP, Cabana M, Castro M, Chanez P, Custovic A, Djukanovic R, Frey U, Frankemolle B, Gibson P, Hamerlijnck D, Jarjour N, Konno S, Shen H, Vitary C, Bush A.

Eur Respir J. 2019 Sep 26. pii: 1900588. doi: 10.1183/13993003.00588-2019. [Epub ahead of print]


Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis.

Hiles SA, McDonald VM, Guilhermino M, Brusselle GG, Gibson PG.

Eur Respir J. 2019 Sep 12. pii: 1901381. doi: 10.1183/13993003.01381-2019. [Epub ahead of print]


Attack, flare-up, or exacerbation? The terminology preferences of patients with severe asthma.

Jones KA, Gibson PG, Yorke J, Niven R, Smith A, McDonald VM.

J Asthma. 2019 Sep 16:1-10. doi: 10.1080/02770903.2019.1665064. [Epub ahead of print]


School-based asthma self-management interventions for children and adolescents with asthma.

Harris K, Kneale D, Lasserson T, McDonald VM, Grigg J, Thomas J.

Paediatr Respir Rev. 2019 Aug;31:40-42. doi: 10.1016/j.prrv.2019.06.005. Epub 2019 Jun 28. Review. No abstract available.


Treatable traits in acute exacerbations of chronic airway diseases.

McDonald VM, Osadnik CR, Gibson PG.

Chron Respir Dis. 2019 Jan-Dec;16:1479973119867954. doi: 10.1177/1479973119867954.


Risk factors of sleep-disordered breathing in haemodialysis patients.

Chu G, Suthers B, Moore L, Paech GM, Hensley MJ, McDonald VM, Choi P.

PLoS One. 2019 Aug 12;14(8):e0220932. doi: 10.1371/journal.pone.0220932. eCollection 2019.


Dysregulation of sputum columnar epithelial cells and products in distinct asthma phenotypes.

Qin L, Gibson PG, Simpson JL, Baines KJ, McDonald VM, Wood LG, Powell H, Fricker M.

Clin Exp Allergy. 2019 Nov;49(11):1418-1428. doi: 10.1111/cea.13452. Epub 2019 Aug 6.


Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes.

Cordova-Rivera L, Gibson PG, Gardiner PA, Hiles SA, McDonald VM.

Respir Med. 2019 Jul - Aug;154:93-101. doi: 10.1016/j.rmed.2019.06.010. Epub 2019 Jun 13.


Treatable traits and their application in high-, middle- and low-income countries.

McDonald VM, Gibson PG.

Respirology. 2019 Oct;24(10):942-943. doi: 10.1111/resp.13626. Epub 2019 Jun 20. No abstract available.


Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report.

McDonald VM, Fingleton J, Agusti A, Hiles SA, Clark VL, Holland AE, Marks GB, Bardin PP, Beasley R, Pavord ID, Wark PAB, Gibson PG; participants of the Treatable Traits Down Under International Workshop; Treatable Traits Down Under International Workshop participants:.

Eur Respir J. 2019 May 9;53(5). pii: 1802058. doi: 10.1183/13993003.02058-2018. Print 2019 May. Review.


School-based self-management interventions for asthma in children and adolescents: a mixed methods systematic review.

Harris K, Kneale D, Lasserson TJ, McDonald VM, Grigg J, Thomas J.

Cochrane Database Syst Rev. 2019 Jan 28;1:CD011651. doi: 10.1002/14651858.CD011651.pub2.


Effectiveness of school-based self-management interventions for asthma among children and adolescents: findings from a Cochrane systematic review and meta-analysis.

Kneale D, Harris K, McDonald VM, Thomas J, Grigg J.

Thorax. 2019 May;74(5):432-438. doi: 10.1136/thoraxjnl-2018-211909. Epub 2019 Jan 27.


Managing patients with severe asthma in Australia: Current challenges with the existing models of care.

Chung LP, Hew M, Bardin P, McDonald VM, Upham JW.

Intern Med J. 2018 Dec;48(12):1536-1541. doi: 10.1111/imj.14103.


Health-related quality of life burden in severe asthma.

McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J.

Med J Aust. 2018 Jul 16;209(S2):S28-S33.


Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD.

Cordova-Rivera L, Gibson PG, Gardiner PA, McDonald VM.

Respirology. 2019 Apr;24(4):352-360. doi: 10.1111/resp.13428. Epub 2018 Nov 1.


Nebulised hypertonic saline for cystic fibrosis.

Wark P, McDonald VM.

Cochrane Database Syst Rev. 2018 Sep 27;9:CD001506. doi: 10.1002/14651858.CD001506.pub4. Review.


Treatable traits can be identified in a severe asthma registry and predict future exacerbations.

McDonald VM, Hiles SA, Godbout K, Harvey ES, Marks GB, Hew M, Peters M, Bardin PG, Reynolds PN, Upham JW, Baraket M, Bhikoo Z, Bowden J, Brockway B, Chung LP, Cochrane B, Foxley G, Garrett J, Jayaram L, Jenkins C, Katelaris C, Katsoulotos G, Koh MS, Kritikos V, Lambert M, Langton D, Lara Rivero A, Middleton PG, Nanguzgambo A, Radhakrishna N, Reddel H, Rimmer J, Southcott AM, Sutherland M, Thien F, Wark PAB, Yang IA, Yap E, Gibson PG.

Respirology. 2019 Jan;24(1):37-47. doi: 10.1111/resp.13389. Epub 2018 Sep 19.


Working while unwell: Workplace impairment in people with severe asthma.

Hiles SA, Harvey ES, McDonald VM, Peters M, Bardin P, Reynolds PN, Upham JW, Baraket M, Bhikoo Z, Bowden J, Brockway B, Chung LP, Cochrane B, Foxley G, Garrett J, Hew M, Jayaram L, Jenkins C, Katelaris C, Katsoulotos G, Koh MS, Kritikos V, Lambert M, Langton D, Lara Rivero A, Marks GB, Middleton PG, Nanguzgambo A, Radhakrishna N, Reddel H, Rimmer J, Southcott AM, Sutherland M, Thien F, Wark PAB, Yang IA, Yap E, Gibson PG.

Clin Exp Allergy. 2018 Jun;48(6):650-662. doi: 10.1111/cea.13153. Epub 2018 May 17.


A Systematic Review of Associations of Physical Activity and Sedentary Time with Asthma Outcomes.

Cordova-Rivera L, Gibson PG, Gardiner PA, McDonald VM.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1968-1981.e2. doi: 10.1016/j.jaip.2018.02.027. Epub 2018 Mar 3.


Severe asthma: We can fix it? We can try!

McDonald VM, Maltby S, Gibson PG.

Respirology. 2018 Mar;23(3):260-261. doi: 10.1111/resp.13249. Epub 2018 Jan 5. No abstract available.


Adherence in severe asthma: time to get it right.

McDonald VM, Yorke J.

Eur Respir J. 2017 Dec 21;50(6). pii: 1702191. doi: 10.1183/13993003.02191-2017. Print 2017 Dec. No abstract available.


Physical Activity and Exercise Capacity in Severe Asthma: Key Clinical Associations.

Cordova-Rivera L, Gibson PG, Gardiner PA, Powell H, McDonald VM.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):814-822. doi: 10.1016/j.jaip.2017.09.022. Epub 2017 Nov 10.


COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.

Yang IA, Brown JL, George J, Jenkins S, McDonald CF, McDonald VM, Phillips K, Smith BJ, Zwar NA, Dabscheck E.

Med J Aust. 2017 Nov 20;207(10):436-442.


Validation of the patient-completed asthma knowledge questionnaire (PAKQ).

Beaurivage D, Boulet LP, Foster JM, Gibson PG, McDonald VM.

J Asthma. 2018 Feb;55(2):169-179. doi: 10.1080/02770903.2017.1318914. Epub 2017 Oct 26.


Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.

Negewo NA, Gibson PG, Wark PA, Simpson JL, McDonald VM.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 6;12:2929-2942. doi: 10.2147/COPD.S136256. eCollection 2017.


The Impact of a Weight Loss Intervention on Diet Quality and Eating Behaviours in People with Obesity and COPD.

McLoughlin RF, McDonald VM, Gibson PG, Scott HA, Hensley MJ, MacDonald-Wicks L, Wood LG.

Nutrients. 2017 Oct 20;9(10). pii: E1147. doi: 10.3390/nu9101147.


Precision medicine in airway diseases: moving to clinical practice.

Agustí A, Bafadhel M, Beasley R, Bel EH, Faner R, Gibson PG, Louis R, McDonald VM, Sterk PJ, Thomas M, Vogelmeier C, Pavord ID; on behalf of all participants in the seminar.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701655. doi: 10.1183/13993003.01655-2017. Print 2017 Oct.


"I have lost in every facet of my life": the hidden burden of severe asthma.

Foster JM, McDonald VM, Guo M, Reddel HK.

Eur Respir J. 2017 Sep 20;50(3). pii: 1700765. doi: 10.1183/13993003.00765-2017. Print 2017 Sep.


Multidimensional assessment of severe asthma: A systematic review and meta-analysis.

Clark VL, Gibson PG, Genn G, Hiles SA, Pavord ID, McDonald VM.

Respirology. 2017 Oct;22(7):1262-1275. doi: 10.1111/resp.13134. Epub 2017 Aug 3. Review.


Sleep disturbance and sleep-disordered breathing in hemodialysis patients.

Chu G, Choi P, McDonald VM.

Semin Dial. 2018 Jan;31(1):48-58. doi: 10.1111/sdi.12617. Epub 2017 Jun 13. Review.


Management of severe asthma: targeting the airways, comorbidities and risk factors.

Gibson PG, McDonald VM.

Intern Med J. 2017 Jun;47(6):623-631. doi: 10.1111/imj.13441. Review.


"To define is to limit": perspectives on asthma-COPD overlap syndrome and personalised medicine.

McDonald VM, Gibson PG.

Eur Respir J. 2017 May 1;49(5). pii: 1700336. doi: 10.1183/13993003.00336-2017. Print 2017 May. No abstract available.


Australian and New Zealand Pulmonary Rehabilitation Guidelines.

Alison JA, McKeough ZJ, Johnston K, McNamara RJ, Spencer LM, Jenkins SC, Hill CJ, McDonald VM, Frith P, Cafarella P, Brooke M, Cameron-Tucker HL, Candy S, Cecins N, Chan AS, Dale MT, Dowman LM, Granger C, Halloran S, Jung P, Lee AL, Leung R, Matulick T, Osadnik C, Roberts M, Walsh J, Wootton S, Holland AE; Lung Foundation Australia and the Thoracic Society of Australia and New Zealand.

Respirology. 2017 May;22(4):800-819. doi: 10.1111/resp.13025. Epub 2017 Mar 24.


Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.

Baines KJ, Fu JJ, McDonald VM, Gibson PG.

Int J Chron Obstruct Pulmon Dis. 2017 Feb 8;12:541-550. doi: 10.2147/COPD.S119443. eCollection 2017.


Obesity in COPD: to treat or not to treat?

McDonald VM, Wood LG, Holland AE, Gibson PG.

Expert Rev Respir Med. 2017 Feb;11(2):81-83. doi: 10.1080/17476348.2017.1267570. Epub 2016 Dec 10. No abstract available.


Severe asthma: Current management, targeted therapies and future directions-A roundtable report.

McDonald VM, Maltby S, Reddel HK, King GG, Wark PA, Smith L, Upham JW, James AL, Marks GB, Gibson PG.

Respirology. 2017 Jan;22(1):53-60. doi: 10.1111/resp.12957. Epub 2016 Nov 30. Review.


Severe asthma: Can we fix it? Prologue to seeking innovative solutions for severe asthma.

McDonald VM, Maltby S, Gibson PG.

Respirology. 2017 Jan;22(1):19-20. doi: 10.1111/resp.12956. Epub 2016 Nov 30. No abstract available.


Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria.

Hew M, Gillman A, Sutherland M, Wark P, Bowden J, Guo M, Reddel HK, Jenkins C, Marks GB, Thien F, Rimmer J, Katsoulotos GP, Cook M, Yang I, Katelaris C, Bowler S, Langton D, Wright C, Bint M, Yozghatlian V, Burgess S, Sivakumaran P, Yan KY, Kritikos V, Peters M, Baraket M, Aminazad A, Robinson P, Jaffe A, Powell H, Upham JW, McDonald VM, Gibson PG.

Clin Exp Allergy. 2016 Nov;46(11):1407-1415. doi: 10.1111/cea.12774. Epub 2016 Jul 22.


Omalizumab Treatment Response in a Population With Severe Allergic Asthma and Overlapping COPD.

Maltby S, Gibson PG, Powell H, McDonald VM.

Chest. 2017 Jan;151(1):78-89. doi: 10.1016/j.chest.2016.09.035. Epub 2016 Oct 11. Erratum in: Chest. 2017 Mar;151(3):730.


Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.

Negewo NA, McDonald VM, Baines KJ, Wark PA, Simpson JL, Jones PW, Gibson PG.

Int J Chron Obstruct Pulmon Dis. 2016 Jul 1;11:1495-504. doi: 10.2147/COPD.S100338. eCollection 2016.


Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry.

Gibson PG, Reddel H, McDonald VM, Marks G, Jenkins C, Gillman A, Upham J, Sutherland M, Rimmer J, Thien F, Katsoulotos GP, Cook M, Yang I, Katelaris C, Bowler S, Langton D, Robinson P, Wright C, Yozghatlian V, Burgess S, Sivakumaran P, Jaffe A, Bowden J, Wark PA, Yan KY, Kritikos V, Peters M, Hew M, Aminazad A, Bint M, Guo M.

Intern Med J. 2016 Sep;46(9):1054-62. doi: 10.1111/imj.13166.


Acute oxygen therapy: a review of prescribing and delivery practices.

Cousins JL, Wark PA, McDonald VM.

Int J Chron Obstruct Pulmon Dis. 2016 May 24;11:1067-75. doi: 10.2147/COPD.S103607. eCollection 2016. Review.


Targeted therapeutics for severe refractory asthma: monoclonal antibodies.

Grainge CL, Maltby S, Gibson PG, Wark PA, McDonald VM.

Expert Rev Clin Pharmacol. 2016 Jul;9(7):927-41. doi: 10.1586/17512433.2016.1172208. Epub 2016 Apr 14. Review.


Diagnosis and investigation in the severe asthma clinic.

Wark PA, Hew M, Maltby S, McDonald VM, Gibson PG.

Expert Rev Respir Med. 2016;10(5):491-503. doi: 10.1586/17476348.2016.1165096. Epub 2016 Mar 25. Review.


Should we treat obesity in COPD? The effects of diet and resistance exercise training.

McDonald VM, Gibson PG, Scott HA, Baines PJ, Hensley MJ, Pretto JJ, Wood LG.

Respirology. 2016 Jul;21(5):875-82. doi: 10.1111/resp.12746. Epub 2016 Feb 24.


Neutrophil extracellular traps are associated with inflammation in chronic airway disease.

Wright TK, Gibson PG, Simpson JL, McDonald VM, Wood LG, Baines KJ.

Respirology. 2016 Apr;21(3):467-75. doi: 10.1111/resp.12730. Epub 2016 Jan 25.


COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species.

Simpson JL, Baines KJ, Horvat JC, Essilfie AT, Brown AC, Tooze M, McDonald VM, Gibson PG, Hansbro PM.

Respirology. 2016 May;21(4):697-704. doi: 10.1111/resp.12734. Epub 2016 Jan 18.


Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma.

Wang G, Baines KJ, Fu JJ, Wood LG, Simpson JL, McDonald VM, Cowan DC, Taylor DR, Cowan JO, Gibson PG.

Eur Respir J. 2016 Apr;47(4):1123-33. doi: 10.1183/13993003.01098-2015. Epub 2015 Dec 23.

Supplemental Content

Loading ...
Support Center